Accuray | ARAY - Cost Of Sales

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $116.17M in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 33.15M 208K Feb/2025
Artivion USD 34.77M 75K Sep/2024
AtriCure USD 35.16M 2.23M Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 253.61M 192.05M Dec/2024
Surmodics USD 33.03M 24.58M Sep/2024
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025